Multiple Sclerosis: Microbiome

Multiple sclerosis (MS) is the most common chronic inflammatory disease of the central nervous system; it is characterized by inflammatory demyelination and neurodegeneration. Here is the latest research into the influence of the human microbiome on this demyelinating disorder.

October 19, 2020

A review on preventive role of ketogenic diet (KD) in CNS disorders from the gut microbiota perspective

Reviews in the Neurosciences
Kajal RawatLekha Saha
April 3, 2020
Review
Open Access

Nutrition, IBD and Gut Microbiota: A Review

Nutrients
Maria Chiara MentellaGiacinto Abele Donato Miggiano
April 4, 2020
Open Access

Microbiome varies between multiple sclerosis subtypes

Nature Reviews. Neurology
Ian Fyfe
October 23, 2020
Review

Dimethyl fumarate induced lymphopenia in multiple sclerosis: A review of the literature

Pharmacology & Therapeutics
Cinzia Dello RussoMunir Pirmohamed
November 4, 2020
Review
Open Access

Pancreatic Diseases and Microbiota: A Literature Review and Future Perspectives

Journal of Clinical Medicine
Marcantonio GesualdoClaudio Giovanni De Angelis
March 8, 2020
Open Access

Perturbation of gut microbiota decreases susceptibility but does not modulate ongoing autoimmune neurological disease

Journal of Neuroinflammation
Clemens GödelGurumoorthy Krishnamoorthy
August 26, 2020
Open Access

Alterations of the gut ecological and functional microenvironment in different stages of multiple sclerosis

Proceedings of the National Academy of Sciences of the United States of America
Daiki TakewakiTakashi Yamamura
October 14, 2020
Open Access

Using data science for medical decision making case: role of gut microbiome in multiple sclerosis

BMC Medical Informatics and Decision Making
Jasminka Hasic Telalovic, Azra Music
August 28, 2020
Review
Open Access

The Effects of Androgens on T Cells: Clues to Female Predominance in Autoimmune Liver Diseases?

Frontiers in Immunology
Lara HenzeChristoph Schramm
June 17, 2020
Open Access

Epstein Barr virus-immortalized B lymphocytes exacerbate experimental autoimmune encephalomyelitis in xenograft mice

Journal of Medical Virology
Pascal PolepoleLuwen Zhang
November 17, 2020
Review
Open Access

Intestinal Dysbiosis in, and Enteral Bacterial Therapies for, Systemic Autoimmune Diseases

Frontiers in Immunology
Eric MariettaJoseph A Murray
March 6, 2020
Open Access

Host and Microbial Tryptophan Metabolic Profiling in Multiple Sclerosis

Frontiers in Immunology
Lorenzo GaetaniTeresa Zelante
April 22, 2020
Comment / Editorial

The future of microbiome research in neuroinflammatory disorders

Multiple Sclerosis and Related Disorders
Emmanuelle WaubantHelen Tremlett
April 9, 2020
Review
Open Access

Fecal Microbiota Transplantation in Neurological Disorders

Frontiers in Cellular and Infection Microbiology
Karuna E W VendrikMaria Fiorella Contarino
February 11, 2020
Review
Open Access

Relationships Between Vitamin D, Gut Microbiome, and Systemic Autoimmunity

Frontiers in Immunology
Erin A Yamamoto, Trine N Jørgensen
April 15, 2020

Deep DNA metagenomic sequencing reveals oral microbiome divergence between monozygotic twins discordant for multiple sclerosis severity

Journal of Neuroimmunology
Anne I BoullerneDouglas L Feinstein
April 17, 2020
Review
Open Access

Microbiome in Multiple Sclerosis; Where Are We, What We Know and Do Not Know

Brain Sciences
Marina Kleopatra BozikiNikolaos Grigoriadis
March 13, 2020
Open Access

Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes

Annals of Clinical and Translational Neurology
Tatjana ReyndersJeroen Raes
September 18, 2020
Open Access

Experimental autoimmune encephalomyelitis is associated with changes of the microbiota composition in the gastrointestinal tract

Scientific Reports
David M JohansonAlban Gaultier
July 1, 2020
Open Access

Rapid improvement in Alzheimer's disease symptoms following fecal microbiota transplantation: a case report

The Journal of International Medical Research
Sabine Hazan

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Acute Hemorrhagic Leukoencephalitis

Acute hemorrhagic leukoencephalitis is a rare form of acute disseminated encephalomyelitis characterized by acute inflammation in the brain and spinal cord that causes demyelination and bleeding. It is often fatal, although treatment with immunosuppressives and plasma exchange can be helpful. Find the latest research on acute hemorrhagic leukoencephalitis here.

© 2021 Meta ULC. All rights reserved
/feed-previews/microbiome-and-ms/300264ee-2362-4185-98b9-a2ca266c176a